Merck KGaA on Thursday forecast currency-adjusted operating earnings growth of up to 8%, helped by demand for semiconductor ...

European discounter Pepco Group said on Thursday it was evaluating all strategic options to separate its struggling 825-store ...

Wiley (NYSE: WLY), one of the world’s largest publishers and a trusted leader in research and learning, today announced the appointment of Karen N. Madden, Ph.D., to its Board of Directors. Madden is ...

MilliporeSigma Chief Technology Officer Brings Extensive Science, Technology, and Innovation Leadership Experience Wiley (NYSE: WLY), one of the world's largest publishers and a trusted leader in ...

We recently published a list of 10 Best Retirement Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Merck KGaA, the German healthcare and technology group, said on Monday it is in advanced talks to acquire U.S. cancer and rare diseases drugmaker SpringWorks Therapeutics. Merck, in a statement, said ...

Also in today’s newsletter, US government spending on consultants and Trump hands carmakers reprieve from tariffs ...

We recently published a list of 10 Best Retirement Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other ...

Merck KGaA, the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases drugmaker Springworks Therapeutics , according to people familiar with the matter.

EMD Group Holding Inc. has received a federal tax lien notice from the Internal Revenue Service indicating it owes over $33.2 million in back taxes. However, the company told the Business Journal that ...

The latest pharma company to make a move for an mRNA specialist is Germany's ... of the pillars of Merck's business, delivered via its process solutions unit, part of the group's life sciences ...

The increasing occurrence of chronic and infectious diseases is the main driver of the rising demand for interferon. Furthermore, advancements in interferon production and ongoing research and ...